Phacilitate Leaders Forum



  • Letter
    • G
  • Michela Gabaldo

    Michela Gabaldo

    Head, Alliance Management & Regulatory Affairs, San Raffaele-Telethon Institute for Gene Therapy
  • Mehdi Gasmi

    Mehdi Gasmi

    Chief Science & Technology Officer, Adverum Biotech
  • Markus Gershater

    Markus Gershater

    Chief Scientific Officer & Co-Founder, Synthace
  • Patrick Ginty

    Patrick Ginty

    Head of Regulatory Affairs, Cell & Gene Therapy Catapult
  • Janet Glassford

    Janet Glassford

    Senior Quality Assessor, Medicines and Healthcare Products Regulatory Agency (MHRA)
  • Clive Glover

    Clive Glover

    Senior Global Marketing Manager, Cell & Gene Therapies, Pall Life Sciences
  • Uta Griesenbach

    Uta Griesenbach

    Professor, Molecular Medicine, National Heart and Lung Institute, Imperial College London
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd